1193434-62-6: Nizatidine EP Impurity F

Status: In-stock

It is an impurity present in nizatidine which says early clinical experience suggests that it is a useful alternative to the histamine H2-receptor antagonists presently in clinical use, after oral administration of nizatidine peak plasma concentrations is achieved within 1 to 3 hours.

Request quotation

Additional information on CAS 1193434-62-6

Catalogue No. VE006309
CAS No. 1193434-62-6
Molecular Formula C15H25N7O4S3 ;
Molecular Weight 463.6
Parent drug Nizatidine
IUPAC Name (EZ)-N1, N1′-[Thiazole-2, 4-diylbis(methylenesulphanediylethylene)] bis(N′-methyl-2-nitroethene-1, 1-diamine)
Synonyms N/A
References “STABILITY-INDICATING LC METHOD for the ESTIMATION of NIZATIDINE IMPURITIES in NIZATIDINE ORAL SOLUTION.” Journal of Liquid Chromatography & Related Technologies, 2014, http://www.tandfonline.com/doi/abs/10.1080/10826076.2013.765461.?Price, Allan H., and Rex N. Brogden. “Nizatidine.” Drugs, vol. 36, no. 5, Nov. 1988, pp. 521–39, https://doi.org/10.2165/00003495-198836050-00002.?
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

1193434-62-6: Nizatidine EP Impurity F

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.